Updates
Update at 13:29 UTC on 2026-03-11
STAT reported Recent developments highlight the FDA's warning to Novo Nordisk and Lilly's strategic investments in China.
Sources: STAT
Novo Nordisk is warned by the FDA for failing to report side effects
It's the third time in recent weeks that the FDA has admonished Novo Nordisk for different practices.